Tag: PLUS.CN

420 with CNW – Finnish Government to Consider Petition to Decriminalize Marijuana

Possession and cultivation of marijuana for personal use is being considered for decriminalization by Finland’s government after marijuana advocates collected the 50,000-plus petition signatures required to prompt the parliament to review the measure.

The proposal stipulates that people found in possession of 25 grams of marijuana or farming a maximum of four plants would not face criminal charges.

The yields of a single marijuana plant are equivalent to the 25 grams permitted under the proposal; therefore, people are urged to dry one plant at a time.

According to Yle, the collection of signatures was started last month by a group called Kasvua Kannabiksesta. Most of the signatures were gathered last month by the Kasvua Kannabikseat group. And, they credited their success to their social media campaigns.

The activist Janne Karvinen said that it is natural for people to do things at the last minute. Recently the group has been promoting the measure through social media. She believes that there are more than 50,000 people in Finland supporting their proposal.

According to the measure, people who consume marijuana in a public space would be charged under new penalties.

A translated explanation of the petition states that the current policy goal is harm reduction, but it has not succeeded. The anti-drug policy is the motive behind the prohibition of marijuana possession and consumption. The ban only targets the minority, and it is harmful to people, and a big waste of law enforcement resources.

The advocates said that imposing criminal charges on marijuana consumers is harmful because no matter how minor the charges are, the misdemeanor offense stays on the person’s records. The advocates also cited the decriminalization model in Portugal, which helped in reducing the number of drug overdoses and people infected with HIV.

The group said that instead of legalizing marijuana, Finland’s government should decriminalize it, as this ensures that it is still adhering to the United Nations rules that stipulate that member countries should not allow marijuana to be legally regulated and sold. However, this has not hindered member countries such as Canada and Uruguay from legalizing cannabis.

According to the proposal, decriminalization is the process of abolishing the criminal aspects of an act that is illegal and punishable by law. The abolished criminal sections may be transformed into a minor offense punishable by a fine.

The Finnish lawmakers will formally debate and consider the decriminalization proposal, but it is still too early to predict whether they will approve or reject the petition.

Analysts think that industry players like Plus Products Inc. (CSE: PLUS) (OTCQB: PLPRF) and VPR Brands LP (OTCQB: VPRB) may be watching the proceedings in Finland closely in order to see whether that part of the continent will eventually allow its citizens to benefit from the jobs, tax revenues and other benefits brought by a regulated marijuana market.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsBreaks – Plus Products Inc. (CSE: PLUS) (OTCQX: PLPRF) Bolsters Research Expertise with Appointment of Chief Scientific Officer Dr. Ari Mackler

Plus Products Inc. (CSE: PLUS) (OTCQX: PLPRF), a leading cannabis branded products company in the U.S., this morning announced the addition of Dr. Ari Mackler as its chief scientific officer. Per the update, Dr. Mackler brings 20 years of medical affairs, communications, and research experience in pharmaceutical, healthcare, and consumer goods industries. The position at PLUS will allow Dr. Mackler to pursue research relationships and clinical trials with private partners and academic institutions in an effort to expand consumer understanding of cannabis and the benefits it may provide. “Dr. Mackler has a long history of helping consumer product companies share a clear and scientifically backed narrative around product benefits,” Plus Products Co-Founder and CEO Jake Heimark said in the news release. “Cannabis is a performance category, and the most successful brands will be those that understand and are able to clearly communicate why their products work. There are few researchers of Dr. Mackler’s caliber in the cannabis industry today, and we believe he will play an invaluable role not only for PLUS, but as a though leader within the industry.”

To view the full press release, visit http://cnw.fm/W38ro

About PLUS

PLUS Products is a hemp and cannabis food company focused on using nature to bring balance to consumers’ lives. PLUS’s mission is to make cannabis safe and approachable – that begins with high-quality products that deliver consistent consumer experiences. PLUS is headquartered in San Mateo, CA with 80 employees. For more information, visit the company’s website at www.PlusProducts.com.

NOTE TO INVESTORS: The latest news and updates relating to PLPRF are available in the company’s newsroom at http://cnw.fm/PLUS

About CanadianCannabisWire

CanadianCannabisWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CanadianCannabisWire.com

Please see full terms of use and disclaimers on the CanadianCannabisWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CanadianCannabisWire (CNW)
Toronto, Ontario
www.CanadianCannabisWire.com
905.674.5977 Office
Editor@CanadianCannabisWire.com

CannabisNewsBreaks – Plus Products Inc. (CSE: PLUS) (OTCQX: PLPRF) to Present at the Benzinga Cannabis Capital Conference in Chicago

Plus Products (CSE: PLUS) (OTCQX: PLPRF), a leading cannabis branded products company in the U.S., this morning announced its plans to present at the Fifth Benzinga Cannabis Capital Conference. The event is slated to be held in Chicago from October 22-23, 2019. Plus Products will present to an audience of public and private companies and fellow institutional, family office and accredited investors looking for the right opportunities in a crowded and volatile market.

To view the full press release, visit http://cnw.fm/S2otp

About Plus Products Inc.

Plus Products Inc. manufactures cannabis products in California. The company offers cannabis-infused edibles to the regulated medicinal and adult-use, or recreational markets. It sells products under the PLUS brand to dispensaries and delivery service customers. The company was incorporated in 2018 and is headquartered in Vancouver, Canada. For more information, visit the company’s website at www.PlusProducts.com.

NOTE TO INVESTORS: The latest news and updates relating to PLPRF are available in the company’s newsroom at http://cnw.fm/PLUS

About CanadianCannabisWire

CanadianCannabisWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CanadianCannabisWire.com

Please see full terms of use and disclaimers on the CanadianCannabisWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CanadianCannabisWire (CNW)
Toronto, Ontario
www.CanadianCannabisWire.com
905.674.5977 Office
Editor@CanadianCannabisWire.com

CBDNewsBreaks – Plus Products Inc. (CSE: PLUS) (OTCQB: PLPRF) Partners with John Legend & Casper Sleep for Nationwide Launch of CBD-Infused Gummies

Plus Products (CSE: PLUS) (OTCQB: PLPRF), a leading cannabis branded products company in the U.S., recently launched a line of 100% hemp, CBD-infused gummies nationwide. An article discussing the company reads, “To support the launch, PLUS has brand partnered with celebrity John Legend and Casper Sleep Inc. Legend will advocate on behalf of the line, while Casper Sleep will partner with PLUS to endorse the new CBD sleep gummies. ‘Like PLUS, we believe sleep is a key part of the wellness equation,’ Neil Parikh, co-founder and chief strategy officer at Casper, stated in a news release (http://cnw.fm/V2eqg). ‘Partnering with their team of experts to introduce CBD sleep gummies brings a new way to relax and rest to those who need it.’ . . . While CBD-focused companies have flooded the market, superstar John Legend was specifically attracted to PLUS Products. ‘I have been a believer in the benefits of CBD for some time,’ Legend added. ‘I was drawn to the PLUS team because they’re an innovative, family-run company, and they use science to deliver a consistent, high-quality product.’ Legend also expressed his appreciation for the ‘high standard’ PLUS has set in the industry.”

To view the full article, visit http://cnw.fm/rcy9I

About PLUS

PLUS Products is a hemp and cannabis food company focused on using nature to bring balance to consumers’ lives. PLUS’s mission is to make cannabis safe and approachable – that begins with high-quality products that deliver consistent consumer experiences. PLUS is headquartered in San Mateo, CA with 80 employees. For more information, visit the company’s website at www.PlusProducts.com.

NOTE TO INVESTORS: The latest news and updates relating to PLPRF are available in the company’s newsroom at http://cnw.fm/PLPRF

About CBDWire

CBDWire (CBDW) is a specialized information provider focused on (1) reporting CBD-related news and updates, (2) releasing CBDNewsBreaks crafted to keep investors abreast of the latest and greatest in the CBD market, (3) refining and enhancing corporate press releases, (4) delivering end-to-end distribution and social media services to client-partners and (5) constructing effective corporate communication solutions based on the unique requirements of CBD companies. CBDW is exclusively positioned in the burgeoning CBD sector with a proven team of journalists and researchers working to deliver high quality content to an expansive target audience of investors, consumers and industry news outlets. Our dissemination network of over 5,000 downstream distribution points allows us to deliver unparalleled reach, visibility and recognition to companies operating in both cannabidiol and the wider cannabis space. CBDWire (CBDW) is where CBD news, content and information converge.

To receive instant SMS alerts, text CBDWire to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CBDWire.com

Please see full terms of use and disclaimers on the CBDWire website applicable to all content provided by CBDW, wherever published or re-published: https://CBDWire.com/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask Our Editor

CBDWire (CBDW)
Denver, Colorado
www.CBDWire.com
303.498.7722 Office
Editor@CBDWire.com

420 with CNW – Federally Funded Study Disproves Marijuana Legalization Myths

A new study on the impacts of marijuana, which was funded by the U.S. Department of Justice, showed that marijuana programs do not affect neighboring or non-legal states negatively.

The new study authors, while conducting their state-level analysis, were looking to answer three questions; first, the impact of legalization on law enforcement resources in legal states. Secondly, how those resources in bordering and non-legal states are affected, and lastly, what it means for drug trafficking after marijuana is legalized.

The researchers used past statistics on drug possession and distribution in the legalized states as well as the neighboring non-legal states to assess the impact of marijuana legalization. The analyzed data showed that legalization did not have any noticeable increase in the number of arrests related to possession or trafficking offenses in legalized or non-legalized states.

Although the Department of Justice funded the study, they do not want the public thinking that they are endorsing the findings because, on every page of the report, there is disclaimer which stresses that the authors’ opinion does not reflect the standpoint or policies of the Department of Justice in the U.S.

The study found that in Washington, there was a decline in the number of possession arrests after cannabis was legalized in 2012, followed by a decrease in distribution arrests after retail sales were introduced.

Marijuana was legalized in 2014 in Oregon, and since the study was carried out in 2015, there was not enough data. However, the little data that was available showed that possession arrests post-legalization dropped close to zero, followed by distribution arrests.

In Oklahoma, which is a non-legal state bordering Colorado, the majority of drug arrests consisted of marijuana possession. However, the number of arrests for marijuana possession declined after marijuana was legalized in Colorado. The number of distribution arrests also decreased, with a small increase in 2013.

There were also noticeable changes in Kansas after marijuana was legalized in the neighboring state of Colorado

The report was supplemented with interviews from law enforcement officials who expressed their concern saying that they have more work due to the perceived increase in young adult usage, THC potency of marijuana, driving under the influence, and an influx of marijuana consumers from non-legal to legal states.

The findings from the Colorado interviews showed that due to the high potency of the THC products, the influence of the drug cartels in the markets has been thwarted. However, in Oregon, there is a spike in drug trafficking by the Afghan and Russian groups stealing marijuana crops and cash from farmers.

The team concluded that, indeed, recreational marijuana legalization results in a dip in possession and trafficking arrests in legalized and non-legal bordering states and that other drugs such as heroin and methamphetamine were the ones having the most impact.

It is believed that marijuana industry players like IONIC Brands Corp. (CSE: IONC) (OTC: IONKF) and Plus Products Inc. (CSE: PLUS) (OTCQB: PLPRF) aren’t surprised by these research findings, and they are glad that the federal government funded the study which debunks the myths regarding marijuana legalization.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsBreaks – Plus Products Inc. (CSE: PLUS) (OTCQB: PLPRF) Announces Launch of Edibles Products into Nevada Adult-Use Cannabis Market

Plus Products Inc. (CSE: PLUS) (OTCQB: PLPRF), a leading cannabis branded products company in the U.S., this morning announced the launch of its best-selling gummies* into the Nevada market. According to the update, the products are manufactured through the company’s partnership with TapRoot Holdings Inc., a vertically integrated cannabis company operating cultivation and manufacturing facilities in Las Vegas, Nevada. Commercialization comes just four months after PLUS and TapRoot’s entry into a definitive agreement. “Operating in Nevada only four months after signing a definitive agreement with TapRoot is a testament to our commitment to execution in building a national footprint,” PLUS Co-Founder and CEO Jake Heimark said in the news release. “We have created and commercialized the best-selling gummies brand in California. Now with this expansion, we aim to replicate this successful strategy in Nevada and ensure high-quality cannabis products reach more consumers in the U.S.”

To view the full press release, visit http://cnw.fm/Q0Ve7

About PLUS

PLUS Products is a hemp and cannabis food company focused on using nature to bring balance to consumers’ lives. PLUS’s mission is to make cannabis safe and approachable – that begins with high-quality products that deliver consistent consumer experiences. PLUS is headquartered in San Mateo, CA with 80 employees. For more information, visit the company’s website at www.PlusProducts.com.

*Over the last twelve months by units and dollars of retail sales according to BDS Analytics

NOTE TO INVESTORS: The latest news and updates relating to PLPRF are available in the company’s newsroom at http://cnw.fm/PLUS

About CanadianCannabisWire

CanadianCannabisWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CanadianCannabisWire.com

Please see full terms of use and disclaimers on the CanadianCannabisWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CanadianCannabisWire (CNW)
Toronto, Ontario
www.CanadianCannabisWire.com
905.674.5977 Office
Editor@CanadianCannabisWire.com

CBDNewsBreaks – Plus Products Inc. (CSE: PLUS) (OTCQX: PLPRF) Launches Nationwide Hemp CBD Product Marketing Campaign

Plus Products (CSE: PLUS) (OTCQX: PLPRF), a leading cannabis branded products company based in California, this morning announced the start of a national marketing campaign featuring the company’s new 100% hemp CBD product. Recently launched in partnership with leading direct-to-consumer sleep company Casper, the new product line will receive additional help from John Legend who will advocate for CBD on behalf of PLUS. PLUS has also partnered with BTTR, an award-winning Los Angeles advertising agency, to design the campaign. Among other highlights, the campaign will include PLUS’s first commercial, which will be featured in digital direct to consumer advertisements; new PLUS hemp CBD products, which consumers can buy and have shipped to them in 43 states through PlusProducts.com; and a buy three for the price of two promotion during the month of October using the promo code ‘PLPRF’. “Marketing is about telling a story to consumers, which is why we are so thrilled by the team we have assembled to help us do just that. Jill Greenberg has brought our products to life by capturing real people and identifiable moments with her photography and BTTR has put those images to work with a beautifully designed campaign,” Plus Products co-founder and CEO Jake Heimark stated in the news release.

To view the full press release, visit http://cnw.fm/khu5J

About PLUS

PLUS Products is a California hemp and cannabis food company focused on using nature to bring balance to consumers’ lives. PLUS’s mission is to make cannabis safe and approachable – that begins with high-quality products that deliver consistent consumer experiences. PLUS is headquartered in San Mateo, CA with 80 employees. For more information, visit the company’s website at www.PlusProducts.com.

NOTE TO INVESTORS: The latest news and updates relating to PLPRF are available in the company’s newsroom at http://cnw.fm/PLPRF

About CBDWire

CBDWire (CBDW) is a specialized information provider focused on (1) reporting CBD-related news and updates, (2) releasing CBDNewsBreaks crafted to keep investors abreast of the latest and greatest in the CBD market, (3) refining and enhancing corporate press releases, (4) delivering end-to-end distribution and social media services to client-partners and (5) constructing effective corporate communication solutions based on the unique requirements of CBD companies. CBDW is exclusively positioned in the burgeoning CBD sector with a proven team of journalists and researchers working to deliver high quality content to an expansive target audience of investors, consumers and industry news outlets. Our dissemination network of over 5,000 downstream distribution points allows us to deliver unparalleled reach, visibility and recognition to companies operating in both cannabidiol and the wider cannabis space. CBDWire (CBDW) is where CBD news, content and information converge.

To receive instant SMS alerts, text CBDWire to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CBDWire.com

Please see full terms of use and disclaimers on the CBDWire website applicable to all content provided by CBDW, wherever published or re-published: https://CBDWire.com/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask Our Editor

CBDWire (CBDW)
Denver, Colorado
www.CBDWire.com
303.498.7722 Office
Editor@CBDWire.com

420 with CNW – A New Study Aims to Find if Marijuana Can be Used to Treat Symptoms of Autism

Montefiore Medical Center in New York is conducting a clinical trial which will examine the effects of cannabidivarin (CBDV) on the level of irritation and repetitive behaviors in autistic children. Cannabidivarin is a compound of marijuana that is nonpsychoactive and does not induce highness upon consumption.

GW Pharmaceuticals grows the cannabis to be used during the research. The company occupies 47-plus acres in the English countryside and is the first drug company to develop cannabis-related medicine which was approved by the U.S. Food and Drug Administration. Two rare types of epilepsy are treated using the drug.

Dr Sanjay Gupta, who is a CNN Chief Medical Correspondent, got exclusive access to the clinical trials In Montefiore Medical Center and GW Pharmaceuticals company.

While reporting for Weed 5 on the cannabinoid craze, Gupta had an exclusive look at GW  cannabis greenhouses. The greenhouses occupy the 47 acres allowing for consistent breeding of different strains of the marijuana crop for medicine. According to David Cooper, head of manufacturing in the company, the process of developing and mastering different strains of the cannabis plant is challenging. During the tour, David showed Gupta the process of turning different strains of the plant into medicine for the large pool of patients.

Gupta also found that GW Pharmaceuticals has been in operation for the last 20 years. Moreover, towards the end of 2018, the company launched Epidiolex.

Epidiolex is the first cannabis-related oral medication to be approved by the FDA. It is used for treating two rare epilepsy disorders. During the clinical trials, Epidiolex reduced the severity of seizure in patients with Dravet Syndrome by an average of 45%-50%. Epidiolex is made of cannadidiol, which is an extracted compound of the cannabis plant.

Epidiolex’s success in treating epilepsy motivated GW Pharmaceutical to manufacture another cannabis-based drug for treating people with a neurological disorder known as autism. Epilepsy and autism have similar symptoms such as loss of cognitive function, poor language skills, and poor socialization skills.

The Director of the AOCD (Autism and Obsessive Compulsive Spectrum, Anxiety and Depression) Program at Montefiore Hospital, Dr Eric Hollander, gets CBDV (cannabidivarin) from GW Pharmaceuticals in UK for the clinical trials. Based on the success of CBDV to reduce seizures, he believes that the hope for treating autism symptoms is in the extract.

Hollander further says that CBDV could help in reducing aggression, self-injury or temper tantrums in autist patients. The clinical trials are headed by Hollander who has 30 years’ experience researching autism. According to Hollander, autism and epilepsy have simiar symptoms.

Autism has no cure. Therefore, Hollander’s focus is on treating the underlying causes of autism, and use of CBDV could help remedy the symptoms.

When CBDV was administered in animals having similar symptoms to autism, the researchers saw that it had significant effect on social functioning, increased cognitive function, less seizures and a reduction in compulsive and repetitive behaviors, thus their application of CBDV on autistic patients.

The clinica trials involve 100 participtants, who are aged between 5-18 years. The treatment takes 12 weeks and will be finalized in September 2021.

It is widely expected that marijuana industry players like IONIC Brands Corp. (CSE: IONC) (OTC: IONKF) and Plus Products Inc. (CSE: PLUS) (OTCQB: PLPRF) will be eager to learn the outcomes of this autism research.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

420 with CNW – Marijuana Legalization Initiative Cleared for Signature Gathering in South Dakota

Marijuana legalization was given the go-ahead for signature collection in South Dakota together with a constitutional amendment meant to legalize hemp and medical marijuana. The motion was introduced in the senate by a former federal prosecutor and was backed by the MPP (Marijuana Policy  Project) and a national cannabis activist group.

The motion to legalize marijuana was filed in June by former U.S Attorney Brenda Johnson. The initiative received the green light for signature collection last week after the attorney general gave the official explanatory statement.

In an interview, Brenda Johnson said that the people of South Dakota are excited and ready to approve a medical marijuana initiative and legalization at the ballot in the coming year.

The initiative which was introduced by the former federal prosecutor would constitute measures to be observed and followed by the residents of South Dakota. The initiative would allow possession and distribution of up to one ounce of marijuana by adults who are 21 years and older. It would permit the residents to cultivate a maximum of three marijuana plants. The issues related with licensing of manufacturers, lab testing facilities and retailers would be tasked to the Department of Revenue in South Dakota.

Sale proceeds of marijuana would be taxed at 15 percent. The tax proceeds would be used to fund the implementation of the weed legalization program, with the extra amounts being used for public education and other state of South Dakota priorities.

Apart from legalizing cannabis, the motion would instruct the legislature to legalize hemp and medical marijuana.

In support of the South Dakota campaign, the Marijuana Policy Project Director, Matthew Schweich told Marijuana Moment that in the U.S., conservative states included, voters are in favour of reforming the marijuana policy. So as an organization, they have to carry out the will of the people when the officials they elected fail to support them.

For marijuana legalization, they must collect 16,961 signatures, and for the proposed constitutional amended to qualify for the ballot box in 2020, they must collect 33,921 signatures from voters. The Marijuana Policy Project involvement will boost the likelihood of the campaign to obtain the required signatures.

The initiative will not pass without resistance since the state’s Republican party are urging the citizens not to sign the petition for the 2020 ballot box while Governor Kristi is rejecting the bill for hemp legalization.

Brenda Johnson, the MPP and others who are for the campaign, “South Dakotans for Better Marijuana Laws” vow to work every day till the day of elections in 2020 to garner support from everyone in the state of South Dakota.

Experts think that marijuana companies like Plus Products Inc. (CSE: PLUS) (OTCQB: PLPRF) and SinglePoint Inc. (OTCQB: SING) will be hoping that voters finally get the chance to decide whether marijuana should or shouldn’t be allowed in South Dakota.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsBreaks – Plus Products Inc. (CSE: PLUS) (OTCQX: PLPRF) Debuts New Line of Best Selling Gummies at Hall of Flowers Cannabis Tradeshow

Plus Products Inc. (CSE: PLUS) (OTCQX: PLPRF), a leading cannabis branded products company based in California, this morning announced the launch of a new line of its best-selling cannabis-infused gummies*. According to the update, the company unveiled its new line at the Hall of Flowers cannabis tradeshow in Santa Rosa, California this past week, rolling out three new flavors of gummies developed by Plus Products’ team of scientists, entrepreneurs and chefs. The new product line includes a balance cucumber lime with 3.5mg THC and 1.5mg CBD per piece; an uplift tangerine with 5mg THC and <0.1mg CBD per piece; and an unwind concord grape with 4.5mg THC and 0.5mg CBD per piece. “The demand from many of our retail partners and consumers to launch a second line of our gummies has been significant and we are excited to expand our product portfolio to meet those demands,” Plus Products CEO and Co-Founder Jake Heimark said in the news release. “We have high expectations given the success of our original line of gummies, which include the #1 & #2 best-selling cannabis products in California**.”

To view the full press release, visit http://cnw.fm/snw4E

About PLUS

PLUS Products is a California hemp and cannabis food company focused on using nature to bring balance to consumers’ lives. PLUS’s mission is to make cannabis safe and approachable – that begins with high-quality products that deliver consistent consumer experiences. PLUS is headquartered in San Mateo, CA with 80 employees. For more information, visit the company’s website at www.PlusProducts.com.

*PLUS is the #1 selling brand of cannabis infused gummies over the last 12 months by dollars of retail sales according to BDS Analytics

**Over the last 12 months by dollars of retail sales according to BDS Analytics

NOTE TO INVESTORS: The latest news and updates relating to PLPRF are available in the company’s newsroom at http://cnw.fm/PLUS

About CanadianCannabisWire

CanadianCannabisWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CanadianCannabisWire.com

Please see full terms of use and disclaimers on the CanadianCannabisWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CanadianCannabisWire (CNW)
Toronto, Ontario
www.CanadianCannabisWire.com
905.674.5977 Office
Editor@CanadianCannabisWire.com